About Adocia
Adocia is a company based in Lyon (France) founded in 2005.. Adocia has raised $26 million across 5 funding rounds from investors including Idinvest Partners, IPF Partners and CDC Enterprises. The company has 77 employees as of December 31, 2024. Adocia offers products and services including BioChaperone® Lispro and Pipeline Products. Adocia operates in a competitive market with competitors including Sana Biotechnology, Semma Therapeutics, Altimmune, Rezolute and Cellino, among others.
- Headquarter Lyon, France
- Employees 77 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Adocia Sa
-
Annual Revenue
$9.68 M (USD)333.49as on Dec 31, 2024
-
Net Profit
$-9.68 M (USD)55.95as on Dec 31, 2024
-
EBITDA
$-10.09 M (USD)43.28as on Dec 31, 2024
-
Total Equity Funding
$26 M (USD)
in 5 rounds
-
Latest Funding Round
$11.73 M (USD), Post-IPO
Dec 18, 2025
-
Investors
Idinvest Partners
& 5 more
-
Employee Count
77
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Adocia
Adocia is a publicly listed company on the EURONEXT with ticker symbol ADOC in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Adocia
Adocia offers a comprehensive portfolio of products and services, including BioChaperone® Lispro and Pipeline Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced insulin product for effective diabetes treatment in clinical settings.
Develops formulations for metabolic hormones targeting diabetes and obesity.
Unlock access to complete
Funding Insights of Adocia
Adocia has successfully raised a total of $26M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $11.73 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $11.7M
-
First Round
First Round
(21 Jan 2008)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Post-IPO - Adocia | Valuation | Stifel |
|
| Feb, 2025 | Amount | Post-IPO - Adocia | Valuation |
investors |
|
| Oct, 2019 | Amount | Debt – Conventional - Adocia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Adocia
Adocia has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Idinvest Partners, IPF Partners and CDC Enterprises. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alternative financing is provided by IPF Partners for healthcare.
|
Founded Year | Domain | Location | |
|
Equity investments are provided to low and middle market companies.
|
Founded Year | Domain | Location | |
|
Smalt Capital is engaged in capital investment and renewable energy financing.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Adocia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Adocia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adocia Comparisons
Competitors of Adocia
Adocia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Semma Therapeutics, Altimmune, Rezolute and Cellino, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Adocia
Frequently Asked Questions about Adocia
When was Adocia founded?
Adocia was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Where is Adocia located?
Adocia is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Is Adocia a funded company?
Adocia is a funded company, having raised a total of $26M across 5 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $16.51M, raised on Jan 21, 2008.
How many employees does Adocia have?
As of Dec 31, 2024, the latest employee count at Adocia is 77.
What is the annual revenue of Adocia?
Annual revenue of Adocia is $9.68M as on Dec 31, 2024.
What does Adocia do?
Adocia was founded in 2005 in Lyon, France, within the biotechnology sector. Therapeutics targeting diabetes and obesity are developed using a proprietary Biochaperone platform, which improves protein effectiveness, safety, and patient administration. The clinical pipeline features a PDGF-BB formulation for diabetic foot ulcers and various insulin options for diabetes management. Operations focus on advancing these protein-based treatments through research and development.
Who are the top competitors of Adocia?
Adocia's top competitors include Imbed Biosciences, Sana Biotechnology and Semma Therapeutics.
What products or services does Adocia offer?
Adocia offers BioChaperone® Lispro and Pipeline Products.
Is Adocia publicly traded?
Yes, Adocia is publicly traded on EURONEXT under the ticker symbol ADOC.
Who are Adocia's investors?
Adocia has 6 investors. Key investors include Idinvest Partners, IPF Partners, CDC Enterprises, Bioam, and Smalt Capital.
What is Adocia's ticker symbol?
The ticker symbol of Adocia is ADOC on EURONEXT.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.